Search

everythinglearnresearchcommunity

for

Search:↓

Microneedle-assisted therapy with human basic fibroblast growth factor significantly regrew hair in patients with hair loss.

Ethosomes could improve how well skin treatments work, but more research is needed on their safety and stability.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

The study aims to create a model to predict health attributes using diverse health data from Japanese adults.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Low iron levels are linked to hair loss in women.

Hair can naturally regain color, and stress might influence greying and its reversal.

The study identified a key protein involved in producing underarm odor and found ways to inhibit it.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

Breathing in high levels of certain air pollutants significantly increases women's risk of developing Polycystic Ovary Syndrome.

CuSi nanowires with NIR photothermal properties could effectively treat infected wounds and promote healing.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Finasteride safely treats enlarged prostate and male-pattern baldness.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Jockeys using diuretics without potassium supplements can face health problems.

Hair loss should be medically treated, as non-medical treatments are ineffective and hair loss can indicate serious health issues.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Minoxidil slows fibroblast growth and collagen production, potentially treating keloids, hypertrophic scars, and connective tissue disorders.

Platelet-rich plasma treatment can significantly increase hair count and density in men with pattern baldness, and these improvements can last up to 3 months.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

Oral minoxidil helps hair regrowth in 80% of alopecia patients, but only 18% see cosmetic improvement.

Late pregnancy helps repair brain damage in rats due to the GABAergic system.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.